GleamWall
中文EN

XTXXF Adastra Holdings Ltd. IFRS Annual reports only

Pharmaceutical Preparations · OTC · SEC CIK 1891512 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2022-12-31 (FY2022), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY136.2%
TTM net income YoY-55.7%
TTM EPS YoY-40.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin46.0%
Operating margin-6.0%
Net margin-32.2%
FCF margin5.2%
EBITDA margin-2.2%

Returns

ROE-21.1%
ROA-14.1%
ROIC (approx.)-3.3%
Asset turnover0.44x

Leverage & solvency

Liabilities / assets42.7%
Debt / equity0.00x
Current ratio0.71x
Interest coverage-2.33x

Cash quality & payout

Operating cash flow / net income-0.31x
Accruals ratio-18.5%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue13.30M5.63M
Cost of revenue7.18M3.68M
Gross profit6.11M1.94M
R&D expense089,268
Operating income-799,996-2.39M
Interest expense343,918276,597
Pretax income-4.34M-2.76M
Income tax-56,000-15,000
Net income-4.28M-2.75M
EBITDA-298,632-2.12M
EPS (basic)-0.07-0.05
EPS (diluted)-0.07-0.05
Weighted avg. shares (diluted)59.23M50.23M
Balance sheet
Cash & equivalents1.01M744,541
Receivables3.56M1.50M
Inventory4.01M1.83M
Current assets9.00M4.22M
PP&E, netmay include right-of-use assets (IFRS)9.73M9.77M
Goodwill9.44M11.11M
Intangibles3.13M3.54M
Total assets31.80M28.76M
Current liabilities12.66M5.34M
Total liabilities13.57M6.38M
Shareholders' equity18.23M22.37M
Shares outstanding55.97M65.97M
Cash flow statement
Operating cash flow1.32M-1.05M
Capital expenditure625,037581,079
Free cash flow694,074-1.64M
Investing cash flow-1.03M-262,811
Financing cash flow-22,548915,984
Depreciation & amortization501,364272,616
Stock-based compensation138,713890,523

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.